Stockreport

TriSalus Life Sciences Announces Pricing of $40.0 Million Public Offering

TriSalus Life Sciences, Inc.  (TLSI) 
PDF WESTMINSTER, Colo.--(BUSINESS WIRE)--TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (“TriSalus” or the “Company”), an oncology focused medical technology company advanc [Read more]